nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ABCB1—Mitomycin—stomach cancer	0.104	0.469	CbGbCtD
Maprotiline—CYP1A2—Fluorouracil—stomach cancer	0.0292	0.132	CbGbCtD
Maprotiline—ABCB1—Irinotecan—stomach cancer	0.0266	0.12	CbGbCtD
Maprotiline—HTR7—myenteric nerve plexus—stomach cancer	0.0201	0.105	CbGeAlD
Maprotiline—ABCB1—Docetaxel—stomach cancer	0.0195	0.0881	CbGbCtD
Maprotiline—ORM1—bile—stomach cancer	0.0193	0.101	CbGeAlD
Maprotiline—CHRM3—muscle of abdomen—stomach cancer	0.0176	0.0924	CbGeAlD
Maprotiline—ABCB1—Doxorubicin—stomach cancer	0.0145	0.0657	CbGbCtD
Maprotiline—ABCB1—Methotrexate—stomach cancer	0.0141	0.0636	CbGbCtD
Maprotiline—CYP2D6—Doxorubicin—stomach cancer	0.0137	0.0619	CbGbCtD
Maprotiline—HTR7—vagus nerve—stomach cancer	0.0134	0.0702	CbGeAlD
Maprotiline—HTR7—vein—stomach cancer	0.0129	0.0678	CbGeAlD
Maprotiline—HTR2A—myenteric nerve plexus—stomach cancer	0.0125	0.0656	CbGeAlD
Maprotiline—HTR2A—vagus nerve—stomach cancer	0.00836	0.0438	CbGeAlD
Maprotiline—HTR2A—vein—stomach cancer	0.00807	0.0423	CbGeAlD
Maprotiline—ORM1—gall bladder—stomach cancer	0.00535	0.028	CbGeAlD
Maprotiline—HTR7—blood vessel—stomach cancer	0.00411	0.0215	CbGeAlD
Maprotiline—CHRM5—epithelium—stomach cancer	0.00376	0.0197	CbGeAlD
Maprotiline—ORM1—hematopoietic system—stomach cancer	0.00303	0.0158	CbGeAlD
Maprotiline—SLC6A3—hematopoietic system—stomach cancer	0.00281	0.0147	CbGeAlD
Maprotiline—HTR2A—blood vessel—stomach cancer	0.00256	0.0134	CbGeAlD
Maprotiline—HTR7—hematopoietic system—stomach cancer	0.00219	0.0115	CbGeAlD
Maprotiline—CHRM3—smooth muscle tissue—stomach cancer	0.00202	0.0106	CbGeAlD
Maprotiline—HTR7—epithelium—stomach cancer	0.002	0.0105	CbGeAlD
Maprotiline—ORM1—bone marrow—stomach cancer	0.00194	0.0102	CbGeAlD
Maprotiline—HTR7—smooth muscle tissue—stomach cancer	0.00193	0.0101	CbGeAlD
Maprotiline—CYP1A2—hematopoietic system—stomach cancer	0.00174	0.00914	CbGeAlD
Maprotiline—ORM1—endocrine gland—stomach cancer	0.00174	0.0091	CbGeAlD
Maprotiline—ABCB1—blood vessel—stomach cancer	0.00168	0.00879	CbGeAlD
Maprotiline—HRH1—hematopoietic system—stomach cancer	0.00163	0.00855	CbGeAlD
Maprotiline—CHRM2—endocrine gland—stomach cancer	0.00162	0.00849	CbGeAlD
Maprotiline—CHRM3—digestive system—stomach cancer	0.0016	0.00837	CbGeAlD
Maprotiline—ORM1—liver—stomach cancer	0.00157	0.00821	CbGeAlD
Maprotiline—HTR7—digestive system—stomach cancer	0.00152	0.00797	CbGeAlD
Maprotiline—HRH1—epithelium—stomach cancer	0.00149	0.00782	CbGeAlD
Maprotiline—CHRM1—endocrine gland—stomach cancer	0.00148	0.00773	CbGeAlD
Maprotiline—HRH1—smooth muscle tissue—stomach cancer	0.00144	0.00753	CbGeAlD
Maprotiline—HTR2A—hematopoietic system—stomach cancer	0.00136	0.00714	CbGeAlD
Maprotiline—CHRM3—endocrine gland—stomach cancer	0.00132	0.00692	CbGeAlD
Maprotiline—SLC6A2—endocrine gland—stomach cancer	0.0013	0.00683	CbGeAlD
Maprotiline—HTR7—endocrine gland—stomach cancer	0.00126	0.00658	CbGeAlD
Maprotiline—HTR2A—epithelium—stomach cancer	0.00125	0.00653	CbGeAlD
Maprotiline—CYP2D6—hematopoietic system—stomach cancer	0.00124	0.00651	CbGeAlD
Maprotiline—CYP1A2—digestive system—stomach cancer	0.00121	0.00635	CbGeAlD
Maprotiline—ORM1—lymph node—stomach cancer	0.0012	0.00629	CbGeAlD
Maprotiline—HTR2A—smooth muscle tissue—stomach cancer	0.0012	0.00629	CbGeAlD
Maprotiline—DRD2—endocrine gland—stomach cancer	0.00119	0.00622	CbGeAlD
Maprotiline—HRH1—digestive system—stomach cancer	0.00114	0.00595	CbGeAlD
Maprotiline—HTR7—liver—stomach cancer	0.00113	0.00594	CbGeAlD
Maprotiline—CYP1A2—endocrine gland—stomach cancer	0.001	0.00525	CbGeAlD
Maprotiline—HTR2A—digestive system—stomach cancer	0.000949	0.00497	CbGeAlD
Maprotiline—HRH1—endocrine gland—stomach cancer	0.000939	0.00492	CbGeAlD
Maprotiline—CYP1A2—liver—stomach cancer	0.000904	0.00473	CbGeAlD
Maprotiline—SLC6A2—lymph node—stomach cancer	0.000902	0.00472	CbGeAlD
Maprotiline—ABCB1—hematopoietic system—stomach cancer	0.000894	0.00468	CbGeAlD
Maprotiline—CYP2D6—digestive system—stomach cancer	0.000864	0.00453	CbGeAlD
Maprotiline—ABCB1—epithelium—stomach cancer	0.000817	0.00428	CbGeAlD
Maprotiline—HTR2A—endocrine gland—stomach cancer	0.000784	0.00411	CbGeAlD
Maprotiline—ABCB1—pancreas—stomach cancer	0.000728	0.00381	CbGeAlD
Maprotiline—CYP2D6—endocrine gland—stomach cancer	0.000714	0.00374	CbGeAlD
Maprotiline—HTR2A—liver—stomach cancer	0.000707	0.0037	CbGeAlD
Maprotiline—HRH1—lymph node—stomach cancer	0.000649	0.0034	CbGeAlD
Maprotiline—CYP2D6—liver—stomach cancer	0.000644	0.00337	CbGeAlD
Maprotiline—ABCB1—lymphoid tissue—stomach cancer	0.000629	0.0033	CbGeAlD
Maprotiline—ABCB1—digestive system—stomach cancer	0.000622	0.00326	CbGeAlD
Maprotiline—ABCB1—bone marrow—stomach cancer	0.000573	0.003	CbGeAlD
Maprotiline—ABCB1—endocrine gland—stomach cancer	0.000514	0.00269	CbGeAlD
Maprotiline—Nortriptyline—HTR1A—stomach cancer	0.000499	0.178	CrCbGaD
Maprotiline—Desipramine—CYP2A6—stomach cancer	0.000472	0.169	CrCbGaD
Maprotiline—ABCB1—liver—stomach cancer	0.000463	0.00243	CbGeAlD
Maprotiline—Desipramine—ADRB1—stomach cancer	0.000459	0.164	CrCbGaD
Maprotiline—Desipramine—HTR1A—stomach cancer	0.000411	0.147	CrCbGaD
Maprotiline—Desipramine—ADRB2—stomach cancer	0.000386	0.138	CrCbGaD
Maprotiline—Anxiety—Capecitabine—stomach cancer	0.000384	0.00108	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000382	0.00108	CcSEcCtD
Maprotiline—Urinary tract disorder—Methotrexate—stomach cancer	0.000382	0.00107	CcSEcCtD
Maprotiline—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000382	0.00107	CcSEcCtD
Maprotiline—Hepatobiliary disease—Epirubicin—stomach cancer	0.000381	0.00107	CcSEcCtD
Maprotiline—Oedema—Docetaxel—stomach cancer	0.000381	0.00107	CcSEcCtD
Maprotiline—Weight increased—Doxorubicin—stomach cancer	0.000381	0.00107	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—stomach cancer	0.000379	0.00107	CcSEcCtD
Maprotiline—Infection—Docetaxel—stomach cancer	0.000379	0.00107	CcSEcCtD
Maprotiline—Weight decreased—Doxorubicin—stomach cancer	0.000378	0.00106	CcSEcCtD
Maprotiline—Diarrhoea—Irinotecan—stomach cancer	0.000377	0.00106	CcSEcCtD
Maprotiline—Dry mouth—Capecitabine—stomach cancer	0.000376	0.00106	CcSEcCtD
Maprotiline—Agranulocytosis—Epirubicin—stomach cancer	0.000376	0.00106	CcSEcCtD
Maprotiline—Shock—Docetaxel—stomach cancer	0.000375	0.00106	CcSEcCtD
Maprotiline—Nervous system disorder—Docetaxel—stomach cancer	0.000374	0.00105	CcSEcCtD
Maprotiline—Pruritus—Fluorouracil—stomach cancer	0.000374	0.00105	CcSEcCtD
Maprotiline—Thrombocytopenia—Docetaxel—stomach cancer	0.000373	0.00105	CcSEcCtD
Maprotiline—Infestation—Doxorubicin—stomach cancer	0.000373	0.00105	CcSEcCtD
Maprotiline—Infestation NOS—Doxorubicin—stomach cancer	0.000373	0.00105	CcSEcCtD
Maprotiline—Drowsiness—Doxorubicin—stomach cancer	0.000373	0.00105	CcSEcCtD
Maprotiline—Confusional state—Capecitabine—stomach cancer	0.000372	0.00105	CcSEcCtD
Maprotiline—Tachycardia—Docetaxel—stomach cancer	0.000372	0.00105	CcSEcCtD
Maprotiline—Skin disorder—Docetaxel—stomach cancer	0.00037	0.00104	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00037	0.00104	CcSEcCtD
Maprotiline—Oedema—Capecitabine—stomach cancer	0.000369	0.00104	CcSEcCtD
Maprotiline—Infection—Capecitabine—stomach cancer	0.000367	0.00103	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—stomach cancer	0.000366	0.00103	CcSEcCtD
Maprotiline—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000366	0.00103	CcSEcCtD
Maprotiline—Dizziness—Irinotecan—stomach cancer	0.000365	0.00103	CcSEcCtD
Maprotiline—Jaundice—Doxorubicin—stomach cancer	0.000364	0.00102	CcSEcCtD
Maprotiline—Stomatitis—Doxorubicin—stomach cancer	0.000364	0.00102	CcSEcCtD
Maprotiline—Shock—Capecitabine—stomach cancer	0.000363	0.00102	CcSEcCtD
Maprotiline—Nervous system disorder—Capecitabine—stomach cancer	0.000362	0.00102	CcSEcCtD
Maprotiline—Hepatitis—Epirubicin—stomach cancer	0.000362	0.00102	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—stomach cancer	0.000361	0.00102	CcSEcCtD
Maprotiline—Diarrhoea—Fluorouracil—stomach cancer	0.000361	0.00102	CcSEcCtD
Maprotiline—Thrombocytopenia—Capecitabine—stomach cancer	0.000361	0.00102	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—stomach cancer	0.00036	0.00101	CcSEcCtD
Maprotiline—Tachycardia—Capecitabine—stomach cancer	0.00036	0.00101	CcSEcCtD
Maprotiline—Hypoaesthesia—Epirubicin—stomach cancer	0.00036	0.00101	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—stomach cancer	0.000359	0.00101	CcSEcCtD
Maprotiline—Skin disorder—Capecitabine—stomach cancer	0.000358	0.00101	CcSEcCtD
Maprotiline—Urinary tract disorder—Epirubicin—stomach cancer	0.000357	0.00101	CcSEcCtD
Maprotiline—Hyperhidrosis—Capecitabine—stomach cancer	0.000357	0.001	CcSEcCtD
Maprotiline—Hypotension—Docetaxel—stomach cancer	0.000356	0.001	CcSEcCtD
Maprotiline—ABCB1—lymph node—stomach cancer	0.000355	0.00186	CbGeAlD
Maprotiline—Urethral disorder—Epirubicin—stomach cancer	0.000355	0.000998	CcSEcCtD
Maprotiline—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000353	0.000992	CcSEcCtD
Maprotiline—Angiopathy—Methotrexate—stomach cancer	0.000351	0.000987	CcSEcCtD
Maprotiline—Vomiting—Irinotecan—stomach cancer	0.000351	0.000986	CcSEcCtD
Maprotiline—Dizziness—Fluorouracil—stomach cancer	0.000349	0.000983	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—stomach cancer	0.000348	0.000981	CcSEcCtD
Maprotiline—Imipramine—HTR1A—stomach cancer	0.000348	0.124	CrCbGaD
Maprotiline—Agranulocytosis—Doxorubicin—stomach cancer	0.000348	0.000979	CcSEcCtD
Maprotiline—Rash—Irinotecan—stomach cancer	0.000348	0.000978	CcSEcCtD
Maprotiline—Dermatitis—Irinotecan—stomach cancer	0.000347	0.000977	CcSEcCtD
Maprotiline—Headache—Irinotecan—stomach cancer	0.000345	0.000972	CcSEcCtD
Maprotiline—Hypotension—Capecitabine—stomach cancer	0.000345	0.00097	CcSEcCtD
Maprotiline—Insomnia—Docetaxel—stomach cancer	0.000345	0.00097	CcSEcCtD
Maprotiline—Paraesthesia—Docetaxel—stomach cancer	0.000342	0.000963	CcSEcCtD
Maprotiline—Erythema multiforme—Epirubicin—stomach cancer	0.000342	0.000963	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—stomach cancer	0.000342	0.000961	CcSEcCtD
Maprotiline—Somnolence—Docetaxel—stomach cancer	0.000339	0.000953	CcSEcCtD
Maprotiline—Eye disorder—Epirubicin—stomach cancer	0.000338	0.000951	CcSEcCtD
Maprotiline—Tinnitus—Epirubicin—stomach cancer	0.000337	0.000949	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—stomach cancer	0.000337	0.000947	CcSEcCtD
Maprotiline—Flushing—Epirubicin—stomach cancer	0.000336	0.000945	CcSEcCtD
Maprotiline—Cardiac disorder—Epirubicin—stomach cancer	0.000336	0.000945	CcSEcCtD
Maprotiline—Vomiting—Fluorouracil—stomach cancer	0.000336	0.000945	CcSEcCtD
Maprotiline—Dyspepsia—Docetaxel—stomach cancer	0.000335	0.000944	CcSEcCtD
Maprotiline—Hepatitis—Doxorubicin—stomach cancer	0.000335	0.000942	CcSEcCtD
Maprotiline—Insomnia—Capecitabine—stomach cancer	0.000334	0.000939	CcSEcCtD
Maprotiline—Hypoaesthesia—Doxorubicin—stomach cancer	0.000333	0.000937	CcSEcCtD
Maprotiline—Rash—Fluorouracil—stomach cancer	0.000333	0.000937	CcSEcCtD
Maprotiline—Dermatitis—Fluorouracil—stomach cancer	0.000333	0.000936	CcSEcCtD
Maprotiline—Paraesthesia—Capecitabine—stomach cancer	0.000331	0.000932	CcSEcCtD
Maprotiline—Headache—Fluorouracil—stomach cancer	0.000331	0.000931	CcSEcCtD
Maprotiline—Urinary tract disorder—Doxorubicin—stomach cancer	0.000331	0.00093	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—stomach cancer	0.00033	0.000927	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000329	0.000926	CcSEcCtD
Maprotiline—Fatigue—Docetaxel—stomach cancer	0.000329	0.000925	CcSEcCtD
Maprotiline—Angiopathy—Epirubicin—stomach cancer	0.000328	0.000924	CcSEcCtD
Maprotiline—Urethral disorder—Doxorubicin—stomach cancer	0.000328	0.000923	CcSEcCtD
Maprotiline—Nausea—Irinotecan—stomach cancer	0.000327	0.000922	CcSEcCtD
Maprotiline—Mediastinal disorder—Epirubicin—stomach cancer	0.000326	0.000918	CcSEcCtD
Maprotiline—Constipation—Docetaxel—stomach cancer	0.000326	0.000917	CcSEcCtD
Maprotiline—Dyspepsia—Capecitabine—stomach cancer	0.000325	0.000914	CcSEcCtD
Maprotiline—Arrhythmia—Epirubicin—stomach cancer	0.000323	0.00091	CcSEcCtD
Maprotiline—Alopecia—Epirubicin—stomach cancer	0.00032	0.0009	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000319	0.000896	CcSEcCtD
Maprotiline—Fatigue—Capecitabine—stomach cancer	0.000318	0.000895	CcSEcCtD
Maprotiline—Vision blurred—Methotrexate—stomach cancer	0.000317	0.000893	CcSEcCtD
Maprotiline—Erythema multiforme—Doxorubicin—stomach cancer	0.000317	0.000891	CcSEcCtD
Maprotiline—Constipation—Capecitabine—stomach cancer	0.000316	0.000888	CcSEcCtD
Maprotiline—Malnutrition—Epirubicin—stomach cancer	0.000315	0.000886	CcSEcCtD
Maprotiline—Feeling abnormal—Docetaxel—stomach cancer	0.000314	0.000884	CcSEcCtD
Maprotiline—Nausea—Fluorouracil—stomach cancer	0.000314	0.000883	CcSEcCtD
Maprotiline—Eye disorder—Doxorubicin—stomach cancer	0.000313	0.00088	CcSEcCtD
Maprotiline—Tinnitus—Doxorubicin—stomach cancer	0.000312	0.000878	CcSEcCtD
Maprotiline—Gastrointestinal pain—Docetaxel—stomach cancer	0.000312	0.000877	CcSEcCtD
Maprotiline—Flushing—Doxorubicin—stomach cancer	0.000311	0.000874	CcSEcCtD
Maprotiline—Cardiac disorder—Doxorubicin—stomach cancer	0.000311	0.000874	CcSEcCtD
Maprotiline—Tension—Epirubicin—stomach cancer	0.000309	0.00087	CcSEcCtD
Maprotiline—Dysgeusia—Epirubicin—stomach cancer	0.000308	0.000868	CcSEcCtD
Maprotiline—Nervousness—Epirubicin—stomach cancer	0.000306	0.000861	CcSEcCtD
Maprotiline—Feeling abnormal—Capecitabine—stomach cancer	0.000304	0.000856	CcSEcCtD
Maprotiline—Angiopathy—Doxorubicin—stomach cancer	0.000304	0.000855	CcSEcCtD
Maprotiline—Gastrointestinal pain—Capecitabine—stomach cancer	0.000302	0.000849	CcSEcCtD
Maprotiline—Mediastinal disorder—Doxorubicin—stomach cancer	0.000302	0.000849	CcSEcCtD
Maprotiline—Abdominal pain—Docetaxel—stomach cancer	0.000301	0.000848	CcSEcCtD
Maprotiline—Body temperature increased—Docetaxel—stomach cancer	0.000301	0.000848	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—stomach cancer	0.000301	0.000848	CcSEcCtD
Maprotiline—Arrhythmia—Doxorubicin—stomach cancer	0.000299	0.000842	CcSEcCtD
Maprotiline—Vision blurred—Epirubicin—stomach cancer	0.000297	0.000835	CcSEcCtD
Maprotiline—Alopecia—Doxorubicin—stomach cancer	0.000296	0.000832	CcSEcCtD
Maprotiline—Urticaria—Capecitabine—stomach cancer	0.000293	0.000825	CcSEcCtD
Maprotiline—Abdominal pain—Capecitabine—stomach cancer	0.000292	0.000821	CcSEcCtD
Maprotiline—Body temperature increased—Capecitabine—stomach cancer	0.000292	0.000821	CcSEcCtD
Maprotiline—Convulsion—Methotrexate—stomach cancer	0.000292	0.000821	CcSEcCtD
Maprotiline—Malnutrition—Doxorubicin—stomach cancer	0.000291	0.00082	CcSEcCtD
Maprotiline—Agitation—Epirubicin—stomach cancer	0.000289	0.000814	CcSEcCtD
Maprotiline—Tension—Doxorubicin—stomach cancer	0.000286	0.000805	CcSEcCtD
Maprotiline—Dysgeusia—Doxorubicin—stomach cancer	0.000285	0.000803	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000285	0.000801	CcSEcCtD
Maprotiline—Nervousness—Doxorubicin—stomach cancer	0.000283	0.000797	CcSEcCtD
Maprotiline—Syncope—Epirubicin—stomach cancer	0.000282	0.000795	CcSEcCtD
Maprotiline—Leukopenia—Epirubicin—stomach cancer	0.000282	0.000793	CcSEcCtD
Maprotiline—Palpitations—Epirubicin—stomach cancer	0.000278	0.000783	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—stomach cancer	0.000277	0.000779	CcSEcCtD
Maprotiline—Loss of consciousness—Epirubicin—stomach cancer	0.000277	0.000779	CcSEcCtD
Maprotiline—Vision blurred—Doxorubicin—stomach cancer	0.000275	0.000773	CcSEcCtD
Maprotiline—Asthenia—Docetaxel—stomach cancer	0.000273	0.000769	CcSEcCtD
Maprotiline—Convulsion—Epirubicin—stomach cancer	0.000273	0.000768	CcSEcCtD
Maprotiline—Infection—Methotrexate—stomach cancer	0.000273	0.000768	CcSEcCtD
Maprotiline—Hypertension—Epirubicin—stomach cancer	0.000272	0.000765	CcSEcCtD
Maprotiline—Pruritus—Docetaxel—stomach cancer	0.00027	0.000759	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—stomach cancer	0.000269	0.000758	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—stomach cancer	0.000269	0.000757	CcSEcCtD
Maprotiline—Agitation—Doxorubicin—stomach cancer	0.000268	0.000754	CcSEcCtD
Maprotiline—Anxiety—Epirubicin—stomach cancer	0.000267	0.000752	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—stomach cancer	0.000267	0.000751	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000266	0.000749	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—stomach cancer	0.000266	0.000747	CcSEcCtD
Maprotiline—Asthenia—Capecitabine—stomach cancer	0.000265	0.000745	CcSEcCtD
Maprotiline—Dry mouth—Epirubicin—stomach cancer	0.000262	0.000738	CcSEcCtD
Maprotiline—Syncope—Doxorubicin—stomach cancer	0.000261	0.000735	CcSEcCtD
Maprotiline—Pruritus—Capecitabine—stomach cancer	0.000261	0.000735	CcSEcCtD
Maprotiline—Leukopenia—Doxorubicin—stomach cancer	0.000261	0.000734	CcSEcCtD
Maprotiline—Diarrhoea—Docetaxel—stomach cancer	0.000261	0.000734	CcSEcCtD
Maprotiline—Confusional state—Epirubicin—stomach cancer	0.000259	0.000729	CcSEcCtD
Maprotiline—Palpitations—Doxorubicin—stomach cancer	0.000258	0.000725	CcSEcCtD
Maprotiline—Oedema—Epirubicin—stomach cancer	0.000257	0.000723	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—stomach cancer	0.000257	0.000722	CcSEcCtD
Maprotiline—Loss of consciousness—Doxorubicin—stomach cancer	0.000256	0.000721	CcSEcCtD
Maprotiline—Infection—Epirubicin—stomach cancer	0.000255	0.000719	CcSEcCtD
Maprotiline—Shock—Epirubicin—stomach cancer	0.000253	0.000712	CcSEcCtD
Maprotiline—Convulsion—Doxorubicin—stomach cancer	0.000253	0.000711	CcSEcCtD
Maprotiline—Diarrhoea—Capecitabine—stomach cancer	0.000252	0.00071	CcSEcCtD
Maprotiline—Nervous system disorder—Epirubicin—stomach cancer	0.000252	0.000709	CcSEcCtD
Maprotiline—Dizziness—Docetaxel—stomach cancer	0.000252	0.000709	CcSEcCtD
Maprotiline—Thrombocytopenia—Epirubicin—stomach cancer	0.000252	0.000708	CcSEcCtD
Maprotiline—Hypertension—Doxorubicin—stomach cancer	0.000252	0.000708	CcSEcCtD
Maprotiline—Tachycardia—Epirubicin—stomach cancer	0.000251	0.000706	CcSEcCtD
Maprotiline—Skin disorder—Epirubicin—stomach cancer	0.00025	0.000703	CcSEcCtD
Maprotiline—Hyperhidrosis—Epirubicin—stomach cancer	0.000249	0.000699	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—stomach cancer	0.000248	0.000699	CcSEcCtD
Maprotiline—Anxiety—Doxorubicin—stomach cancer	0.000247	0.000696	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—stomach cancer	0.000247	0.000694	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000246	0.000693	CcSEcCtD
Maprotiline—Somnolence—Methotrexate—stomach cancer	0.000244	0.000687	CcSEcCtD
Maprotiline—Dizziness—Capecitabine—stomach cancer	0.000244	0.000687	CcSEcCtD
Maprotiline—Dry mouth—Doxorubicin—stomach cancer	0.000243	0.000683	CcSEcCtD
Maprotiline—Vomiting—Docetaxel—stomach cancer	0.000242	0.000682	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—stomach cancer	0.000242	0.00068	CcSEcCtD
Maprotiline—Rash—Docetaxel—stomach cancer	0.00024	0.000676	CcSEcCtD
Maprotiline—Hypotension—Epirubicin—stomach cancer	0.00024	0.000676	CcSEcCtD
Maprotiline—Dermatitis—Docetaxel—stomach cancer	0.00024	0.000676	CcSEcCtD
Maprotiline—Confusional state—Doxorubicin—stomach cancer	0.00024	0.000675	CcSEcCtD
Maprotiline—Headache—Docetaxel—stomach cancer	0.000239	0.000672	CcSEcCtD
Maprotiline—Oedema—Doxorubicin—stomach cancer	0.000238	0.000669	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000237	0.000667	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—stomach cancer	0.000237	0.000666	CcSEcCtD
Maprotiline—Infection—Doxorubicin—stomach cancer	0.000236	0.000665	CcSEcCtD
Maprotiline—Vomiting—Capecitabine—stomach cancer	0.000235	0.00066	CcSEcCtD
Maprotiline—Shock—Doxorubicin—stomach cancer	0.000234	0.000658	CcSEcCtD
Maprotiline—Nervous system disorder—Doxorubicin—stomach cancer	0.000233	0.000656	CcSEcCtD
Maprotiline—Thrombocytopenia—Doxorubicin—stomach cancer	0.000233	0.000655	CcSEcCtD
Maprotiline—Rash—Capecitabine—stomach cancer	0.000233	0.000655	CcSEcCtD
Maprotiline—Insomnia—Epirubicin—stomach cancer	0.000233	0.000654	CcSEcCtD
Maprotiline—Dermatitis—Capecitabine—stomach cancer	0.000232	0.000654	CcSEcCtD
Maprotiline—Tachycardia—Doxorubicin—stomach cancer	0.000232	0.000653	CcSEcCtD
Maprotiline—Headache—Capecitabine—stomach cancer	0.000231	0.00065	CcSEcCtD
Maprotiline—Skin disorder—Doxorubicin—stomach cancer	0.000231	0.00065	CcSEcCtD
Maprotiline—Paraesthesia—Epirubicin—stomach cancer	0.000231	0.00065	CcSEcCtD
Maprotiline—Hyperhidrosis—Doxorubicin—stomach cancer	0.00023	0.000647	CcSEcCtD
Maprotiline—Somnolence—Epirubicin—stomach cancer	0.000229	0.000643	CcSEcCtD
Maprotiline—Nausea—Docetaxel—stomach cancer	0.000226	0.000637	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—stomach cancer	0.000226	0.000637	CcSEcCtD
Maprotiline—Dyspepsia—Epirubicin—stomach cancer	0.000226	0.000637	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—stomach cancer	0.000225	0.000632	CcSEcCtD
Maprotiline—Nortriptyline—ALB—stomach cancer	0.000224	0.08	CrCbGaD
Maprotiline—Hypotension—Doxorubicin—stomach cancer	0.000222	0.000625	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000222	0.000624	CcSEcCtD
Maprotiline—Fatigue—Epirubicin—stomach cancer	0.000222	0.000624	CcSEcCtD
Maprotiline—Constipation—Epirubicin—stomach cancer	0.00022	0.000619	CcSEcCtD
Maprotiline—Nausea—Capecitabine—stomach cancer	0.000219	0.000617	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—stomach cancer	0.000218	0.000614	CcSEcCtD
Maprotiline—Abdominal pain—Methotrexate—stomach cancer	0.000217	0.000611	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—stomach cancer	0.000217	0.000611	CcSEcCtD
Maprotiline—Insomnia—Doxorubicin—stomach cancer	0.000215	0.000605	CcSEcCtD
Maprotiline—Paraesthesia—Doxorubicin—stomach cancer	0.000214	0.000601	CcSEcCtD
Maprotiline—Feeling abnormal—Epirubicin—stomach cancer	0.000212	0.000596	CcSEcCtD
Maprotiline—Somnolence—Doxorubicin—stomach cancer	0.000211	0.000595	CcSEcCtD
Maprotiline—Gastrointestinal pain—Epirubicin—stomach cancer	0.00021	0.000592	CcSEcCtD
Maprotiline—Dyspepsia—Doxorubicin—stomach cancer	0.000209	0.000589	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000205	0.000578	CcSEcCtD
Maprotiline—Fatigue—Doxorubicin—stomach cancer	0.000205	0.000577	CcSEcCtD
Maprotiline—Urticaria—Epirubicin—stomach cancer	0.000204	0.000575	CcSEcCtD
Maprotiline—Constipation—Doxorubicin—stomach cancer	0.000203	0.000572	CcSEcCtD
Maprotiline—Abdominal pain—Epirubicin—stomach cancer	0.000203	0.000572	CcSEcCtD
Maprotiline—Body temperature increased—Epirubicin—stomach cancer	0.000203	0.000572	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—stomach cancer	0.000197	0.000555	CcSEcCtD
Maprotiline—Feeling abnormal—Doxorubicin—stomach cancer	0.000196	0.000552	CcSEcCtD
Maprotiline—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000195	0.000547	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—stomach cancer	0.000194	0.000547	CcSEcCtD
Maprotiline—Urticaria—Doxorubicin—stomach cancer	0.000189	0.000532	CcSEcCtD
Maprotiline—Body temperature increased—Doxorubicin—stomach cancer	0.000188	0.000529	CcSEcCtD
Maprotiline—Abdominal pain—Doxorubicin—stomach cancer	0.000188	0.000529	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—stomach cancer	0.000188	0.000529	CcSEcCtD
Maprotiline—Asthenia—Epirubicin—stomach cancer	0.000184	0.000519	CcSEcCtD
Maprotiline—Pruritus—Epirubicin—stomach cancer	0.000182	0.000512	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—stomach cancer	0.000182	0.000511	CcSEcCtD
Maprotiline—Diarrhoea—Epirubicin—stomach cancer	0.000176	0.000495	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—stomach cancer	0.000175	0.000491	CcSEcCtD
Maprotiline—Rash—Methotrexate—stomach cancer	0.000173	0.000487	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—stomach cancer	0.000173	0.000487	CcSEcCtD
Maprotiline—Headache—Methotrexate—stomach cancer	0.000172	0.000484	CcSEcCtD
Maprotiline—Asthenia—Doxorubicin—stomach cancer	0.000171	0.00048	CcSEcCtD
Maprotiline—Dizziness—Epirubicin—stomach cancer	0.00017	0.000478	CcSEcCtD
Maprotiline—Pruritus—Doxorubicin—stomach cancer	0.000168	0.000474	CcSEcCtD
Maprotiline—Vomiting—Epirubicin—stomach cancer	0.000163	0.00046	CcSEcCtD
Maprotiline—Nausea—Methotrexate—stomach cancer	0.000163	0.000459	CcSEcCtD
Maprotiline—Diarrhoea—Doxorubicin—stomach cancer	0.000163	0.000458	CcSEcCtD
Maprotiline—Rash—Epirubicin—stomach cancer	0.000162	0.000456	CcSEcCtD
Maprotiline—Dermatitis—Epirubicin—stomach cancer	0.000162	0.000456	CcSEcCtD
Maprotiline—Headache—Epirubicin—stomach cancer	0.000161	0.000453	CcSEcCtD
Maprotiline—Dizziness—Doxorubicin—stomach cancer	0.000157	0.000443	CcSEcCtD
Maprotiline—Nausea—Epirubicin—stomach cancer	0.000153	0.00043	CcSEcCtD
Maprotiline—Vomiting—Doxorubicin—stomach cancer	0.000151	0.000426	CcSEcCtD
Maprotiline—Rash—Doxorubicin—stomach cancer	0.00015	0.000422	CcSEcCtD
Maprotiline—Dermatitis—Doxorubicin—stomach cancer	0.00015	0.000422	CcSEcCtD
Maprotiline—Headache—Doxorubicin—stomach cancer	0.000149	0.000419	CcSEcCtD
Maprotiline—Nausea—Doxorubicin—stomach cancer	0.000141	0.000398	CcSEcCtD
Maprotiline—CHRM3—Metabolism—PTGS2—stomach cancer	1.12e-05	4.9e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ERCC2—stomach cancer	1.12e-05	4.88e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.12e-05	4.88e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—stomach cancer	1.12e-05	4.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	1.12e-05	4.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EGFR—stomach cancer	1.12e-05	4.86e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB2—stomach cancer	1.12e-05	4.86e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	1.11e-05	4.81e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK3—stomach cancer	1.1e-05	4.81e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SERPINE1—stomach cancer	1.1e-05	4.81e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—stomach cancer	1.1e-05	4.8e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTP1—stomach cancer	1.1e-05	4.79e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—KRAS—stomach cancer	1.09e-05	4.76e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—STAT3—stomach cancer	1.09e-05	4.75e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	1.09e-05	4.74e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	1.09e-05	4.73e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	1.09e-05	4.72e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMOX1—stomach cancer	1.08e-05	4.72e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SERPINE1—stomach cancer	1.08e-05	4.72e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	1.08e-05	4.71e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	1.08e-05	4.7e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	1.08e-05	4.69e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	1.08e-05	4.69e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—KRAS—stomach cancer	1.08e-05	4.68e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MYC—stomach cancer	1.07e-05	4.67e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—KRAS—stomach cancer	1.07e-05	4.67e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—KRAS—stomach cancer	1.07e-05	4.66e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	1.07e-05	4.65e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	1.07e-05	4.64e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—KRAS—stomach cancer	1.07e-05	4.64e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RHOA—stomach cancer	1.06e-05	4.64e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL8—stomach cancer	1.06e-05	4.61e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—KRAS—stomach cancer	1.06e-05	4.6e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—stomach cancer	1.06e-05	4.59e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—stomach cancer	1.05e-05	4.59e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—stomach cancer	1.05e-05	4.59e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—HRAS—stomach cancer	1.05e-05	4.58e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK1—stomach cancer	1.05e-05	4.57e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EGFR—stomach cancer	1.05e-05	4.57e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RHOA—stomach cancer	1.05e-05	4.56e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RHOA—stomach cancer	1.05e-05	4.55e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—STAT3—stomach cancer	1.05e-05	4.55e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK3—stomach cancer	1.04e-05	4.54e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RHOA—stomach cancer	1.04e-05	4.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RHOA—stomach cancer	1.04e-05	4.52e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—stomach cancer	1.04e-05	4.51e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—stomach cancer	1.03e-05	4.5e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	1.03e-05	4.5e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CAV1—stomach cancer	1.03e-05	4.49e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—stomach cancer	1.03e-05	4.49e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOA1—stomach cancer	1.03e-05	4.48e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RHOA—stomach cancer	1.03e-05	4.48e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—stomach cancer	1.03e-05	4.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TYMS—stomach cancer	1.02e-05	4.45e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—stomach cancer	1.02e-05	4.43e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MYC—stomach cancer	1.01e-05	4.41e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTM1—stomach cancer	1.01e-05	4.4e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—stomach cancer	1.01e-05	4.38e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	1e-05	4.37e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK3—stomach cancer	9.98e-06	4.35e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—KRAS—stomach cancer	9.92e-06	4.32e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK1—stomach cancer	9.92e-06	4.32e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EGFR—stomach cancer	9.92e-06	4.32e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	9.88e-06	4.3e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCND1—stomach cancer	9.87e-06	4.3e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB2—stomach cancer	9.86e-06	4.29e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	9.86e-06	4.29e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—JUN—stomach cancer	9.85e-06	4.29e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	9.83e-06	4.28e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	9.79e-06	4.26e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CAV1—stomach cancer	9.72e-06	4.23e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MYC—stomach cancer	9.71e-06	4.23e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOA1—stomach cancer	9.7e-06	4.22e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB2—stomach cancer	9.7e-06	4.22e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	9.7e-06	4.22e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB2—stomach cancer	9.68e-06	4.21e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB2—stomach cancer	9.65e-06	4.2e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB2—stomach cancer	9.62e-06	4.19e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—stomach cancer	9.58e-06	4.17e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	9.55e-06	4.16e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB2—stomach cancer	9.52e-06	4.15e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ERCC2—stomach cancer	9.5e-06	4.14e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK1—stomach cancer	9.5e-06	4.14e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EGFR—stomach cancer	9.5e-06	4.13e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—KRAS—stomach cancer	9.37e-06	4.08e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL8—stomach cancer	9.35e-06	4.07e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK8—stomach cancer	9.32e-06	4.06e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HRAS—stomach cancer	9.29e-06	4.04e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL8—stomach cancer	9.2e-06	4e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL8—stomach cancer	9.18e-06	4e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL8—stomach cancer	9.15e-06	3.98e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—HRAS—stomach cancer	9.14e-06	3.98e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDKN1B—stomach cancer	9.13e-06	3.97e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL8—stomach cancer	9.12e-06	3.97e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HRAS—stomach cancer	9.12e-06	3.97e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PIK3CA—stomach cancer	9.12e-06	3.97e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HRAS—stomach cancer	9.09e-06	3.96e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARG—stomach cancer	9.07e-06	3.95e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HRAS—stomach cancer	9.06e-06	3.94e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL8—stomach cancer	9.03e-06	3.93e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	8.98e-06	3.91e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HRAS—stomach cancer	8.97e-06	3.91e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—KRAS—stomach cancer	8.97e-06	3.91e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDKN1B—stomach cancer	8.96e-06	3.9e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	8.94e-06	3.89e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—stomach cancer	8.93e-06	3.89e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	8.91e-06	3.88e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—stomach cancer	8.89e-06	3.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	8.82e-06	3.84e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—stomach cancer	8.82e-06	3.84e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—stomach cancer	8.75e-06	3.81e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—stomach cancer	8.73e-06	3.8e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCND1—stomach cancer	8.71e-06	3.79e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—stomach cancer	8.7e-06	3.79e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—JUN—stomach cancer	8.69e-06	3.78e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—stomach cancer	8.67e-06	3.78e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	8.61e-06	3.75e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—stomach cancer	8.6e-06	3.75e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—stomach cancer	8.59e-06	3.74e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCND1—stomach cancer	8.57e-06	3.73e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—JUN—stomach cancer	8.55e-06	3.72e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCND1—stomach cancer	8.55e-06	3.72e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARG—stomach cancer	8.55e-06	3.72e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—JUN—stomach cancer	8.53e-06	3.71e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCND1—stomach cancer	8.52e-06	3.71e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—STAT3—stomach cancer	8.52e-06	3.71e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—JUN—stomach cancer	8.51e-06	3.7e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCND1—stomach cancer	8.5e-06	3.7e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—JUN—stomach cancer	8.48e-06	3.69e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—stomach cancer	8.46e-06	3.68e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HRAS—stomach cancer	8.43e-06	3.67e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDKN1A—stomach cancer	8.43e-06	3.67e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCND1—stomach cancer	8.41e-06	3.66e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—JUN—stomach cancer	8.4e-06	3.66e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—stomach cancer	8.33e-06	3.62e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—stomach cancer	8.32e-06	3.62e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—stomach cancer	8.3e-06	3.61e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	8.29e-06	3.61e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—stomach cancer	8.28e-06	3.6e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDKN1A—stomach cancer	8.27e-06	3.6e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—stomach cancer	8.25e-06	3.59e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	8.25e-06	3.59e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	8.24e-06	3.59e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAV1—stomach cancer	8.24e-06	3.59e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK8—stomach cancer	8.22e-06	3.58e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	8.22e-06	3.58e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOA1—stomach cancer	8.22e-06	3.58e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—stomach cancer	8.17e-06	3.56e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—stomach cancer	8.16e-06	3.55e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	8.14e-06	3.54e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK3—stomach cancer	8.14e-06	3.54e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK8—stomach cancer	8.09e-06	3.52e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK8—stomach cancer	8.07e-06	3.51e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—stomach cancer	8.07e-06	3.51e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK8—stomach cancer	8.05e-06	3.5e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK8—stomach cancer	8.02e-06	3.49e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—stomach cancer	7.97e-06	3.47e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HRAS—stomach cancer	7.96e-06	3.47e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK8—stomach cancer	7.94e-06	3.46e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MYC—stomach cancer	7.92e-06	3.45e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.87e-06	3.43e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—stomach cancer	7.8e-06	3.4e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK1—stomach cancer	7.74e-06	3.37e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EGFR—stomach cancer	7.74e-06	3.37e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—stomach cancer	7.69e-06	3.35e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HRAS—stomach cancer	7.63e-06	3.32e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—stomach cancer	7.62e-06	3.32e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—stomach cancer	7.59e-06	3.31e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—STAT3—stomach cancer	7.52e-06	3.27e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—stomach cancer	7.47e-06	3.25e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—stomach cancer	7.46e-06	3.25e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—stomach cancer	7.43e-06	3.23e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—stomach cancer	7.41e-06	3.22e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—STAT3—stomach cancer	7.4e-06	3.22e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—STAT3—stomach cancer	7.38e-06	3.21e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—STAT3—stomach cancer	7.36e-06	3.2e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—stomach cancer	7.35e-06	3.2e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—stomach cancer	7.34e-06	3.19e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—STAT3—stomach cancer	7.33e-06	3.19e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—KRAS—stomach cancer	7.31e-06	3.18e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—stomach cancer	7.3e-06	3.18e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—STAT3—stomach cancer	7.26e-06	3.16e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARG—stomach cancer	7.24e-06	3.15e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK3—stomach cancer	7.18e-06	3.13e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—stomach cancer	7.14e-06	3.11e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK3—stomach cancer	7.07e-06	3.08e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK3—stomach cancer	7.05e-06	3.07e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK3—stomach cancer	7.03e-06	3.06e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK3—stomach cancer	7.01e-06	3.05e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MYC—stomach cancer	6.99e-06	3.04e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK3—stomach cancer	6.94e-06	3.02e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PIK3CA—stomach cancer	6.92e-06	3.01e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MYC—stomach cancer	6.87e-06	2.99e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MYC—stomach cancer	6.86e-06	2.99e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MYC—stomach cancer	6.84e-06	2.98e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK1—stomach cancer	6.83e-06	2.98e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EGFR—stomach cancer	6.83e-06	2.97e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MYC—stomach cancer	6.82e-06	2.97e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MYC—stomach cancer	6.75e-06	2.94e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK1—stomach cancer	6.72e-06	2.93e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—stomach cancer	6.72e-06	2.93e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EGFR—stomach cancer	6.72e-06	2.93e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	6.72e-06	2.93e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK1—stomach cancer	6.71e-06	2.92e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EGFR—stomach cancer	6.71e-06	2.92e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK1—stomach cancer	6.69e-06	2.91e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EGFR—stomach cancer	6.69e-06	2.91e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK1—stomach cancer	6.67e-06	2.9e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EGFR—stomach cancer	6.67e-06	2.9e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK1—stomach cancer	6.6e-06	2.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EGFR—stomach cancer	6.6e-06	2.87e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—stomach cancer	6.51e-06	2.83e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—stomach cancer	6.5e-06	2.83e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—KRAS—stomach cancer	6.46e-06	2.81e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—KRAS—stomach cancer	6.35e-06	2.76e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—KRAS—stomach cancer	6.34e-06	2.76e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—KRAS—stomach cancer	6.32e-06	2.75e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—KRAS—stomach cancer	6.3e-06	2.74e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—KRAS—stomach cancer	6.24e-06	2.71e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—stomach cancer	6.23e-06	2.71e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HRAS—stomach cancer	6.22e-06	2.71e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—stomach cancer	5.95e-06	2.59e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3CA—stomach cancer	5.93e-06	2.58e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	5.84e-06	2.54e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3CA—stomach cancer	5.82e-06	2.53e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	5.8e-06	2.53e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	5.79e-06	2.52e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—stomach cancer	5.74e-06	2.5e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	5.73e-06	2.49e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—stomach cancer	5.7e-06	2.48e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—stomach cancer	5.65e-06	2.46e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—stomach cancer	5.63e-06	2.45e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—stomach cancer	5.61e-06	2.44e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—stomach cancer	5.6e-06	2.44e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—stomach cancer	5.54e-06	2.41e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HRAS—stomach cancer	5.49e-06	2.39e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HRAS—stomach cancer	5.4e-06	2.35e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HRAS—stomach cancer	5.39e-06	2.35e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HRAS—stomach cancer	5.37e-06	2.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HRAS—stomach cancer	5.35e-06	2.33e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HRAS—stomach cancer	5.3e-06	2.31e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—stomach cancer	5.25e-06	2.29e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—stomach cancer	5.17e-06	2.25e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—stomach cancer	5.16e-06	2.24e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—stomach cancer	5.14e-06	2.24e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—stomach cancer	5.12e-06	2.23e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—stomach cancer	5.07e-06	2.21e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CA—stomach cancer	4.39e-06	1.91e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CA—stomach cancer	4.14e-06	1.8e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CA—stomach cancer	3.5e-06	1.53e-05	CbGpPWpGaD
